Lenox Wealth Advisors’s Boston Scientific BSX Stock Holding History

Lenox Wealth Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$5K	Buy	110 +77	+233%	+$3.34K	﹤0.01%	555
2021 Q4	$1K	Buy	+33	New	+$1.39K	﹤0.01%	806
2020 Q3	–	Sell	-74	Closed	-$3K	–	575
2020 Q2	$3K	Sell	74 -129	-64%	-$4.65K	﹤0.01%	476
2020 Q1	$7K	Buy	203 +74	+57%	+$2.89K	﹤0.01%	379
2019 Q4	$6K	Buy	129 +120	+1,333%	+$5.02K	﹤0.01%	459
2019 Q3	$0	Hold	9	–	–	﹤0.01%	617
2019 Q2	$0	Buy	+9	New	+$346	﹤0.01%	432

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Lenox Wealth Advisors's BSX Position: Q1 2022 in Review

Lenox Wealth Advisors increased its Boston Scientific (BSX) stake by 233% in Q1 2022, buying an estimated $3.34K and bringing the position to 110 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #555.

Lenox Wealth Advisors first reported a position in BSX in Q2 2019 and has held it in 7 quarters since. The position peaked at $7K in Q1 2020. 905 funds tracked by Wall St. Rank hold BSX as of Q1 2022.

Lenox Wealth Advisors held 110 shares of Boston Scientific worth $5K as of Q1 2022.
Lenox Wealth Advisors bought 77 Boston Scientific shares in Q1 2022, an estimated $3.34K.
Boston Scientific made up ﹤0.01% of Lenox Wealth Advisors's portfolio in Q1 2022, its #555 holding.
Lenox Wealth Advisors first reported a position in Boston Scientific in Q2 2019 and has held it in 7 quarters since.
Lenox Wealth Advisors's Boston Scientific position peaked at $7K in Q1 2020.
905 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2022.

Based on Lenox Wealth Advisors's 13F filing for Q1 2022, filed 14 Apr 2022.